These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30990966)

  • 21. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
    Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
    Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
    Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
    Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orally administered mesoporous silica capped with the cucurbit[8]uril complex to combat colitis and improve intestinal homeostasis by targeting the gut microbiota.
    Cheng S; Shen H; Zhao S; Zhang Y; Xu H; Wang L; Di B; Xu L; Hu C
    Nanoscale; 2020 Jul; 12(28):15348-15363. PubMed ID: 32648873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.
    Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA
    J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery.
    Qiu XL; Li QL; Zhou Y; Jin XY; Qi AD; Yang YW
    Chem Commun (Camb); 2015 Mar; 51(20):4237-40. PubMed ID: 25670321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
    J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
    Ding X; Yu W; Wan Y; Yang M; Hua C; Peng N; Liu Y
    Carbohydr Polym; 2020 Oct; 245():116493. PubMed ID: 32718608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cucurbit[7]uril containers for targeted delivery of oxaliplatin to cancer cells.
    Cao L; Hettiarachchi G; Briken V; Isaacs L
    Angew Chem Int Ed Engl; 2013 Nov; 52(46):12033-7. PubMed ID: 24039074
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual-pH/Magnetic-Field-Controlled Drug Delivery Systems Based on Fe
    Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W
    ChemMedChem; 2017 Oct; 12(19):1600-1609. PubMed ID: 28857472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
    Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
    Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme-inspired controlled release of cucurbit[7]uril nanovalves by using magnetic mesoporous silica.
    Liu J; Du X; Zhang X
    Chemistry; 2011 Jan; 17(3):810-5. PubMed ID: 21226095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pH-responsive dissociable mesoporous silica-based nanoplatform enabling efficient dual-drug co-delivery and rapid clearance for cancer therapy.
    He Y; Shao L; Usman I; Hu Y; Pan A; Liang S; Xu H
    Biomater Sci; 2020 Jun; 8(12):3418-3429. PubMed ID: 32405634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
    González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
    Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance.
    Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.